Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)

Publication | Closed Access

DOI

Citations

References

2008

Year

Georgia Schilling, M. Bruweleit, Nadia Harbeck, Christoph Thomssen, Karl‐Friedrich Becker, Ramona Hoffmann, C. Villena, M. Schütte, Dieter K. Hossfeld, Carsten Bokemeyer,

Investigational New Drugs

Breast OncologyPhase Ii TrialCombination ChemotherapyOpen LabelMedicinePharmacologyClinical TrialsBreast CancerPharmacotherapyCancer TreatmentOncology